Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Extra Collagen
- Development stage
- Unknown
- Lead developer
- Medis Group
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Extra Collagen is a nutraceutical product developed and marketed by MédiS Group, a pharmaceutical company based in Tunisia. It is provided in the form of granules for oral solution, typically packaged in sachets for convenient administration. As a collagen-based dietary supplement, it is intended to support the maintenance of connective tissues, including skin, hair, nails, and joints, by providing the necessary amino acid building blocks for endogenous collagen synthesis. The product is part of MédiS Group's consumer health portfolio and is distributed primarily in the North African market.
- Brand names
- Extra Collagen
Beyond the preview
Go deeper on Extra Collagen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Extra Collagen.